Concepedia

Yu Liang

YL

Statistics

Publications

2

Citations

87

H-Index

2

Active since

2012

Affiliations

Qingdao University(Current)

Yu Liang is an author at Qingdao University specializing in medicine, oncology, and s100 protein expression.

ORCID

Publications per year

2012–2017

2

Publications

2

CX-1158-101: A first-in-human phase 1 study of CB-1158, a small molecule inhibitor of arginase, as monotherapy and in combination with an anti-PD-1 checkpoint inhibitor in patients (pts) with solid tumors.

Kyriakos P. Papadopoulos, Frank Tsai, Todd M. Bauer et al. · Journal of Clinical Oncology · 2017 · 45 citations

, , +17

S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.

Lin Wang, Xingang Wang, Yu Liang et al. · Acta Biochimica Polonica · 2012 · 42 citations · Full text

, , +17

1–2 of 2